Free Helpline
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
A detailed guide to Leqvio (inclisiran) dosage, administration, and its role in managing high cholesterol for Indian patients, including approved uses, dosing schedules, and important considerations.
High cholesterol is a significant health concern for many Indians, contributing to serious cardiovascular issues. Leqvio, with its active ingredient inclisiran, offers a novel approach to managing high cholesterol, particularly for those with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. This article provides a detailed guide to Leqvio dosage, administration, and its role in a comprehensive cholesterol management plan, tailored for the Indian context.
Leqvio belongs to a class of drugs known as small interfering RNA (siRNA). It works by targeting and reducing the production of PCSK9 protein in the liver. PCSK9 normally breaks down LDL (low-density lipoprotein) cholesterol receptors on the liver surface. By reducing PCSK9, Leqvio increases the number of LDL receptors, which in turn helps the liver remove more LDL cholesterol from the bloodstream. This mechanism is different from traditional statins and offers a new therapeutic option.
Leqvio is approved in India for adults with:
It is typically used in conjunction with diet and other cholesterol-lowering treatments, such as statins, for patients who cannot achieve their LDL cholesterol goals with existing therapies.
The standard dosage of Leqvio is 284 milligrams (mg) per 1.5 milliliters (mL). This dosage is administered as an injection under the skin (subcutaneously).
The Leqvio injection is given according to a specific schedule:
This dosing regimen means that after the initial two doses, patients typically only need to receive the injection twice a year, making it a convenient option for long-term management.
Leqvio comes in a single-dose, prefilled syringe. A qualified healthcare professional (doctor, nurse, or trained medical staff) will administer the injection. The injection can be given in:
It is crucial that Leqvio is administered by a healthcare provider to ensure correct technique and monitoring for any immediate reactions.
No, Leqvio's dosage is not based on body weight. The recommended dose of 284 mg is the same for all adult patients, regardless of their weight. This standardized dosing simplifies treatment and ensures consistent efficacy across different patient profiles.
Leqvio is often prescribed as part of a broader cholesterol management strategy. Your doctor will likely continue or initiate other treatments alongside Leqvio, including:
Always adhere strictly to your doctor's recommendations regarding all medications and lifestyle modifications.
It is important to consult your doctor if:
Currently, Leqvio has not been approved by regulatory bodies like the FDA for use in children. Treatment options for high cholesterol in children are different and should be discussed with a pediatrician or a pediatric cardiologist.
A1: The active ingredient in Leqvio is inclisiran.
A2: Leqvio is given as an injection on day 1, then again at 3 months, and subsequently every 6 months.
A3: No, Leqvio must be administered by a healthcare professional.
A4: Common side effects include reactions at the injection site, such as pain, redness, or itching, and sometimes flu-like symptoms.
A5: No, Leqvio is not a statin. It belongs to a different class of drugs called siRNA, although it is often used in combination with statins.
A6: Leqvio is specifically approved for adults with heterozygous familial hypercholesterolemia and atherosclerotic cardiovascular disease. It may not be suitable for all forms of hyperlipidemia.
Leqvio represents a significant advancement in the management of high cholesterol for specific patient groups in India. Its unique mechanism of action and convenient dosing schedule can improve adherence and long-term outcomes. Understanding the correct dosage, administration, and its place within a comprehensive treatment plan is crucial for effective cholesterol management. Always consult your healthcare provider for personalized advice and treatment decisions.
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.
Confused about whether CBD can get you high? Understand the difference between CBD and THC, their effects on your body, and what to look for in safe, non-intoxicating CBD products.
April 1, 2026
Learn about anticoagulants and antiplatelet drugs, often called blood thinners. Understand how they prevent blood clots, when they're prescribed, their side effects, and essential safety tips for Indian readers.
April 1, 2026
Confused about Plan B and abortion pills? Understand the key differences, how they work, and their effectiveness for informed reproductive health decisions.
April 1, 2026